Category: Health Science
-
Lophos Pharma (MESC.C) now readies for natural and synthetic peyote production
Lophos Pharmaceuticals Corp. (MESC.C), a key player in the Canadian biosciences/psychedelics sector, has made a significant leap forward in the field of psychoactive compound research and development as it has announced the successful finalization of a new synthetic mescaline production protocol, marking a major milestone in the accessibility and study of psychoactive substances. This development…
-
Revive Therapeutics (RVV.C) takes on long covid with new phase 2/3 FDA protocol
Allow me to back into the lede a bit here. THE STORY OF ROCKERFELLER VS THE WORMS In the early part of the 20th century, the American South was known colloquially as ‘the hookworm belt.’ Hookworms are parasites that like a human host. They corkscrew into your feet when you walk by them barefoot, travel…
-
![Markets slip as CPI remains above expectations 01-16-24]()
Markets slip as CPI remains above expectations 01-16-24
The TSX dipped 1% this morning to 20907.44. TSX Venture fell similarly to 558.82 while the CSE Composite dropped 2.3% to 186.26. CPI numbers remained sticky, dampening hopes of a March rate cut. Valeo Pharma Market segments remained relatively flat with Telecom, Information Technology, Healthcare and Battery Metals marginally in the green. Valeo Pharma (VPH.T)…
-
![Stocks go green as Deloitte predicts spring rate cut 01-04-23]()
Stocks go green as Deloitte predicts spring rate cut 01-04-23
The TSX bumped 56.43 to 20875.01. TSX Venture moved up 1.11 to 551.18 while the CSE Composite edged higher to 170.32. There was a sense of positivity in the markets after Deloitte Canada predicted BoC would cut rates in the spring and even though H1 will see stagnant growth as a hangover from last years…
-
![Optimi Health (OPTI.C) transforming psychedelic treatment and wellness]()
Optimi Health (OPTI.C) transforming psychedelic treatment and wellness
In Canada, the prevalence of depression and mental health disorders has shown a worrying increase. According to data from 2022, over 5 million Canadians, accounting for 18% of the population aged 15 and older. This growing trend underscores the importance of addressing mental health issues at a societal and policy level, with an emphasis on…
-
![VentriPoint Diagnostics (VPT.V): A powerful new AI-powered face in cardiac care]()
VentriPoint Diagnostics (VPT.V): A powerful new AI-powered face in cardiac care
Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States, costing approximately $239.9 billion in 2019 alone due to the cost of health care services, medicines, and lost productivity due to death, not to mention the emotional toll on patients and their friends and…
-
![Perimeter Medical Imaging AI (PINK.V) Changing the Outcomes of Breast Cancer Surgery]()
Perimeter Medical Imaging AI (PINK.V) Changing the Outcomes of Breast Cancer Surgery
Breast cancer is the most diagnosed cancer among Canadian women and is the 2nd leading cause of cancer death. One in eight Canadian women can expect to receive a breast cancer diagnosis during their lifetime with a 19% chance of dying from the disease. Breast cancer surgery is often required, and patient outcomes are heavily…
-
![InnoCan Pharma’s (CSE: INNO) investment potential in the Pharmaceuticals Sector: A Balanced View]()
InnoCan Pharma’s (CSE: INNO) investment potential in the Pharmaceuticals Sector: A Balanced View
InnoCan Pharma Corporation, trading on the Canadian Securities Exchange under the symbol INNO, FSE: IP4, and OTC: INNPF, is a pharmaceutical technology company that has garnered attention in the investment community. This article evaluates its potential as an investment option in the pharmaceuticals space, considering both its recent achievements and challenges. Business Model and Strategic…
-
![Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets]()
Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets
Several years back, Hugh Rogers was in my office talking about his cannabis company. Way back then, the plan was to grow in Germany and be first on the continent, using an old wartime bunker as a ‘safe growing facility’. Those plans morphed quickly as the reality of the cannabis space became clear. The cannabis…
-
![Revive Therapeutics (RVV.C) finds multiple research options moving forward]()
Revive Therapeutics (RVV.C) finds multiple research options moving forward
In Canada, if you look backwards over the timeline, you’ll often find public companies have been other things back in the day. Risen, fallen, tapped out, rolled back, reemerged as a whole new thing. Sometimes this happens several times before a business model catches. Revive Therapeutics (RVV.C) is that rare Canadian smallcap that, while it…
